about
The ANG-(1-7)/ACE2/mas axis in the regulation of nephron functionAngiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor MasA systematic review to investigate whether Angiotensin-(1-7) is a promising therapeutic target in human heart failureMultifaceted interplay among mediators and regulators of intestinal glucose absorption: potential impacts on diabetes research and treatmentAdvances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular functionPharmacological effects of AVE 0991, a nonpeptide angiotensin-(1-7) receptor agonistOcular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in RatsCooperation between mast cell carboxypeptidase A and the chymase mouse mast cell protease 4 in the formation and degradation of angiotensin IIAngiotensin-(1-7) attenuates the chronotropic response to angiotensin II via stimulation of PTEN in the spontaneously hypertensive rat neurons.AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal functionLocalization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan.Antenatal betamethasone exposure alters renal responses to angiotensin-(1-7) in uninephrectomized adult male sheep.Inhibitory effects of angiotensin-(1-7) on the nerve stimulation-induced release of norepinephrine and neuropeptide Y from the mesenteric arterial bed.Impairment of the Plasmodium falciparum erythrocytic cycle induced by angiotensin peptides.Angiotensin-converting enzyme inhibition, but not AT(1) receptor blockade, in the solitary tract nucleus improves baroreflex sensitivity in anesthetized transgenic hypertensive (mRen2)27 rats.Regulation of the renal proximal tubule second sodium pump by angiotensins.Angiotensin-(1-7) increases neuronal potassium current via a nitric oxide-dependent mechanismBioactive angiotensin peptides: focus on angiotensin IV.Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats.ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.Angiotensin-(1-7) is involved in the endothelium-dependent modulation of phenylephrine-induced contraction in the aorta of mRen-2 transgenic ratsCellular targets for angiotensin II fragments: pharmacological and molecular evidence.The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction.Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system.Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT2R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studiesAVE0991, a Nonpeptide Compound, Attenuates Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation via Induction of Heme Oxygenase-1 and Downregulation of p-38 MAPK Phosphorylation.Angiotensin-(1-7)-mediated signaling in cardiomyocytes.Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapyReduced circulating levels of angiotensin-(1--7) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control.Megalin binds and internalizes angiotensin-(1-7).Cardiovascular actions of angiotensin-(1-7).Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs.International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Angiotensin peptides and their pleiotropic actions.Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model.Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.Angiotensin-converting enzyme 2 and the kidney.Angiotensin-converting enzyme 2 activation improves endothelial functionAngiotensin-converting enzyme 2 overexpression improves central nitric oxide-mediated sympathetic outflow in chronic heart failure.Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2.
P2860
Q24633556-48F780EB-5141-4F90-921E-F2BD5493E431Q24680069-50350E0A-CE7E-4ABC-BEFE-AE7D90A17C2AQ27021559-627AC8C9-F3ED-4817-9807-F91441969151Q28086792-149F4A2A-95E0-40D5-AE95-08066976B5ACQ28264715-8269BB36-7F4E-4191-A174-DEA41E7FB3C6Q28282619-53B59CF3-C856-42CF-A930-F65795BB9EB8Q28546739-75D36833-0031-4861-9DA9-44854CA9F028Q28592232-18BDE924-B722-4C9F-88F2-714351F250E9Q29347114-C62FC31F-0A3D-4428-A28F-677EDED57FCDQ30415577-55093A6A-883C-4F48-BF10-5B1C69CB8BE8Q33384087-255B55C7-03B4-4FEA-91A2-B0616CAA9A5DQ33609249-8894905F-90EA-4CE6-84AB-C409E0A7D945Q33655956-B45A9974-C771-489B-A759-6EF27429EE72Q33833640-F220BE5D-E910-446D-8FCB-8A74C364E7A1Q34163441-53615727-9D5C-4FFF-8F39-468A6E7BB3ABQ34318297-B14B525A-FD0E-43FF-B9D8-1984964F4767Q34501670-E8D67EF6-06DF-4E71-97FF-61870ACEBBD1Q34553630-93C9876E-931E-40FA-9DDF-1F90ECBE4964Q34719150-A9FD3D28-0657-416D-8AC1-D7D5887D14ABQ34784864-5D638F7F-1F9A-4482-8D90-9DC96E0D14CEQ35044273-8862C55F-14F3-471F-A8F5-EAC2AA956C64Q35065512-73034F13-4C31-4DCC-BB44-AE10F582D3C2Q35148421-0120C5A7-ABD9-431C-8954-5FF267489A51Q35567432-7A3F6DC1-7673-4E86-BD84-6B0B8A0DC14BQ35786784-A73C51E2-1A70-42FD-A173-80BE4F40CEFBQ35821431-54F02606-2B33-4878-A834-7D8B33429605Q35829928-4E8EE18F-8D98-4A38-B3C0-5193E9E0C5E0Q36013124-77EC4206-B0CD-4048-B4BB-22774E3EFA7EQ36013823-86818A33-CE20-4AC3-BF3E-AAF4598C5F5CQ36088785-781FF581-86A7-4EE9-9D99-22B2BDA7E112Q36165955-119F58DD-6ABC-4199-B144-5446231A5B2FQ36210919-4FB197EE-7330-4E72-9D75-7824C1B51298Q36241932-1E5D0E16-8FA4-4DAA-9026-EB46E09562DEQ36416940-24F8BDEF-38BE-4E37-8740-002C6FBA7B8CQ36720577-11412AB1-4586-4FCB-93AC-08E6F7CA1392Q37045324-0D4FC066-F3A1-42C5-A3E7-4F63ACFB022EQ37068454-66379B78-E082-4198-9114-C5D87977CFEBQ37069541-83D040B2-9179-47E1-9CE7-301035733E3CQ37079211-51777817-BDDF-4793-9E94-A2E2222EEC98Q37085063-F6E69E8F-8355-458B-ACEE-00AC536AFE8E
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Angiotensin-(1-7): an update.
@ast
Angiotensin-(1-7): an update.
@en
type
label
Angiotensin-(1-7): an update.
@ast
Angiotensin-(1-7): an update.
@en
prefLabel
Angiotensin-(1-7): an update.
@ast
Angiotensin-(1-7): an update.
@en
P1433
P1476
Angiotensin-(1-7): an update
@en
P2093
S P Andrade
P356
10.1016/S0167-0115(00)00138-5
P577
2000-07-01T00:00:00Z